The etiopathogenesis of Alzheimer's disease (AD) is puzzled by the heterogeneous nature of this neurodegenerative disorder. In recent years, clinical and basic research has accentuated a relationship between post-traumatic stress disorder (PTSD) and AD risk. Despite several pathways related to neuroinflammation, metabolic disturbances, and stress, emerging evidence implicates genetic risks at the nexus of PTSD and AD. However, the shared susceptibility genes and potential polygenic overlap between the two conditions is relatively understudied.
Objective
This study aims to assess the shared genetic risk between AD and PTSD by leveraging large-scale genomic sequencing data through hippocampus-specific transcriptome-wide association studies (TWAS).
Methods
We focused on a shared vulnerable brain region between AD and PTSD, the hippocampus, to investigate shared genetic risks between the two brain disorders. Functional annotation for TWAS-identified cross-disease susceptibility genes was performed to identify AD/PTSD-related biological pathways.
Results
FUSION TWAS analysis identified 120 susceptibility genes common to both disorders at the nominal significance of 0.05. Further functional annotation uncovered multiple pivotal biological pathways, especially those related to cell metabolism. Metabolic pathway analysis topped lipid metabolism-related pathways such as “acyl-CoA hydrolysis” that overlaps AD and PTSD risk. Deregulation of these common susceptibility genes in the hippocampus may potentiate PTSD and AD in sequence through hippocampal dysmetabolism.
Conclusions
These preliminary findings from computational analysis shed light on the genetic association between AD and PTSD, which will endorse further investigation through experimental approaches for a better understanding of the link between the two conditions from a perspective of precision medicine.
HampelHHardyJBlennowK, et al.The amyloid-beta pathway in Alzheimer's disease. Mol Psychiatry2021; 26: 5481–5503.
3.
LitkeRGarcharnaLCJiwaniS, et al.Modifiable risk factors in Alzheimer disease and related dementias: a review. Clin Ther2021; 43: 953–965.
4.
BaumgartMSnyderHMCarrilloMC, et al.Summary of the evidence on modifiable risk factors for cognitive decline and dementia: a population-based perspective. Alzheimers Dement2015; 11: 718–726.
5.
MannSKMarwahaRTorricoTJ. Posttraumatic stress disorder. Treasure Island, FL: StatPearls, 2025.
6.
QureshiSUKimbrellTPyneJM, et al.Greater prevalence and incidence of dementia in older veterans with posttraumatic stress disorder. J Am Geriatr Soc2010; 58: 1627–1633.
7.
WeinerMWVeitchDPHayesJ, et al.Effects of traumatic brain injury and posttraumatic stress disorder on Alzheimer's disease in veterans, using the Alzheimer's Disease Neuroimaging Initiative. Alzheimers Dement2014; 10: S226–S235.
8.
Alves de Araujo JuniorDSairHIPetersME, et al.The association between post-traumatic stress disorder (PTSD) and cognitive impairment: a systematic review of neuroimaging findings. J Psychiatr Res2023; 164: 259–269.
9.
XieHClaycomb ErwinMElhaiJD, et al.Relationship of hippocampal volumes and posttraumatic stress disorder symptoms over early posttrauma periods. Biol Psychiatry Cogn Neurosci Neuroimaging2018; 3: 968–975.
10.
LambertHKMcLaughlinKA. Impaired hippocampus-dependent associative learning as a mechanism underlying PTSD: a meta-analysis. Neurosci Biobehav Rev2019; 107: 729–749.
11.
RaoYLGanarajaBMurlimanjuBV, et al.Hippocampus and its involvement in Alzheimer's disease: a review. 3 Biotech2022; 12: 55.
12.
WoodwardMBennettDARundekT, et al.The relationship between hippocampal changes in healthy aging and Alzheimer's disease: a systematic literature review. Front Aging Neurosci2024; 16: 1390574.
13.
AverillLAPurohitPAverillCL, et al.Glutamate dysregulation and glutamatergic therapeutics for PTSD: evidence from human studies. Neurosci Lett2017; 649: 147–155.
14.
WangRReddyPH. Role of glutamate and NMDA receptors in Alzheimer's disease. J Alzheimers Dis2017; 57: 1041–1048.
15.
Azargoonjahromi A and Alzheimer's Disease Neuroimaging Initiative. Serotonin enhances neurogenesis biomarkers, hippocampal volumes, and cognitive functions in Alzheimer's disease. Mol Brain2024; 17: 93.
16.
MurroughJWHuangYHuJ, et al.Reduced amygdala serotonin transporter binding in posttraumatic stress disorder. Biol Psychiatry2011; 70: 1033–1038.
17.
Agis-BalboaRCPinheiroPSRebolaN, et al.Formin 2 links neuropsychiatric phenotypes at young age to an increased risk for dementia. EMBO J2017; 36: 2815–2828.
18.
SunEMotolaniACamposL, et al.The pivotal role of NF-kB in the pathogenesis and therapeutics of Alzheimer's disease. Int J Mol Sci2022; 23: 8972.
19.
LutzMWLuoSWilliamsonDE, et al.Shared genetic etiology underlying late-onset Alzheimer's disease and posttraumatic stress syndrome. Alzheimers Dement2020; 16: 1280–1292.
20.
AbdellaouiAYengoLVerweijKJH, et al.15 Years of GWAS discovery: realizing the promise. Am J Hum Genet2023; 110: 179–194.
21.
TamVPatelNTurcotteM, et al.Benefits and limitations of genome-wide association studies. Nat Rev Genet2019; 20: 467–484.
22.
GedikHPetersonRERileyBP, et al.Integrative post-genome-wide association study analyses relevant to psychiatric disorders: imputing transcriptome and proteome signals. Complex Psychiatry2023; 9: 130–144.
23.
KorteAFarlowA. The advantages and limitations of trait analysis with GWAS: a review. Plant Methods2013; 9: 29.
24.
Pereira CiochettiNLugli-MoraesBSantos da SilvaB, et al.Genome-wide association studies: utility and limitations for research in physiology. J Physiol2023; 601: 2771–2799.
25.
MaiJLuMGaoQ, et al.Transcriptome-wide association studies: recent advances in methods, applications and available databases. Commun Biol2023; 6: 899.
26.
EvansPNagaiTKonkashbaevA, et al.Transcriptome-wide association studies (TWAS): methodologies, applications, and challenges. Curr Protoc2024; 4: e981.
27.
WangXWangMWangH, et al.Drug repurposing for Alzheimer's disease integrating transcriptome-wide association study and biological network analysis. J Alzheimers Dis2025; 107: 314–327.
28.
ShanYHuHYangA, et al.An integrative approach to identifying NPC1 as a susceptibility gene for gestational diabetes mellitus. J Matern Fetal Neonatal Med2025; 38: 2445665.
29.
KucukaliFHillEWatzeelsT, et al.Multiomic analyses direct hypotheses for creutzfeldt-jakob disease risk genes. Brain2025; 148: 3350–3363.
30.
GlausierJREnwrightJFLewisDA. Cortical transcriptomic profiling reveals cellular and mitochondrial adaptive stress signatures that differ between schizophrenia and bipolar disorder. Schizophr Bull. Epub ahead of print 24 Sep 2025; DOI: 10.1093/schbul/sbaf147.
31.
ShiJZhangL. Transcriptome-wide association studies integrating four levels identify novel targets for idiopathic pulmonary fibrosis. Curr Med ChemEpub ahead of print 26 August 2025; 32. DOI: 10.2174/0109298673364730250721151447.
32.
TianJJiaKWangT, et al.Hippocampal transcriptome-wide association study and pathway analysis of mitochondrial solute carriers in Alzheimer's disease. Transl Psychiatry2024; 14: 250.
33.
GusevAKoAShiH, et al.Integrative approaches for large-scale transcriptome-wide association studies. Nat Genet2016; 48: 245–252.
34.
JansenIESavageJEWatanabeK, et al.Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk. Nat Genet2019; 51: 404–413.
35.
NievergeltCMMaihoferAXAtkinsonEG, et al.Genome-wide association analyses identify 95 risk loci and provide insights into the neurobiology of post-traumatic stress disorder. Nat Genet2024; 56: 792–808.
36.
GreeneCSKrishnanAWongAK, et al.Understanding multicellular function and disease with human tissue-specific networks. Nat Genet2015; 47: 569–576.
37.
CZI Cell Science Program, AbdullaSAevermannB, et al. CZ CELLxGENE Discover: a single-cell data platform for scalable exploration, analysis and modeling of aggregated data. Nucleic Acids Res2025; 53: D886–D900.
38.
YoonSBaikBParkT, et al.Powerful p-value combination methods to detect incomplete association. Sci Rep2021; 11: 6980.
39.
ZhangYLiuGYanJ, et al.Metabolic learning and memory formation by the brain influence systemic metabolic homeostasis. Nat Commun2015; 6: 6704.
40.
CarneiroLKnaufCMansuy-AubertV. Editorial: neural control of energy homeostasis and energy homeostasis regulation of brain function. Front Neurosci2022; 16: 872296.
41.
MichopoulosVVesterANeighG. Posttraumatic stress disorder: a metabolic disorder in disguise?Exp Neurol2016; 284: 220–229.
42.
MellonSHGautamAHammamiehR, et al.Metabolism, metabolomics, and inflammation in posttraumatic stress disorder. Biol Psychiatry2018; 83: 866–875.
43.
YuanYZhaoGZhaoY. Dysregulation of energy metabolism in Alzheimer's disease. J Neurol2024; 272: 2.
44.
YinFSanchetiHPatilI, et al.Energy metabolism and inflammation in brain aging and Alzheimer's disease. Free Radic Biol Med2016; 100: 108–122.
45.
BanoDEhningerDBagettaG. Decoding metabolic signatures in Alzheimer's disease: a mitochondrial perspective. Cell Death Discov2023; 9: 432.
46.
WeiZKoyaJReznikSE. Insulin resistance exacerbates Alzheimer disease via multiple mechanisms. Front Neurosci2021; 15: 687157.
47.
FeringaFMvan der KantR. Cholesterol and Alzheimer's disease; from risk genes to pathological effects. Front Aging Neurosci2021; 13: 690372.
48.
BhatiaSRawalRSharmaP, et al.Mitochondrial dysfunction in Alzheimer's disease: opportunities for drug development. Curr Neuropharmacol2022; 20: 675–692.
49.
PszczolowskaMWalczakKMiskowW, et al.Mitochondrial disorders leading to Alzheimer's disease-perspectives of diagnosis and treatment. Geroscience2024; 46: 2977–2988.
50.
JiaKTianJWangT, et al.Mitochondria-sequestered Abeta renders synaptic mitochondria vulnerable in the elderly with a risk of Alzheimer disease. JCI Insight2023; 8: e174290.
51.
RobertsALAgnew-BlaisJCSpiegelmanD, et al.Posttraumatic stress disorder and incidence of type 2 diabetes mellitus in a sample of women: a 22-year longitudinal study. JAMA Psychiatry2015; 72: 203–210.
52.
FarrOMSloanDMKeaneTM, et al.Stress- and PTSD-associated obesity and metabolic dysfunction: a growing problem requiring further research and novel treatments. Metabolism2014; 63: 1463–1468.
53.
OgawaSHoriHNiwaM, et al.Serum lipid and plasma fatty acid profiles in PTSD patients and healthy individuals: associations with symptoms, cognitive function, and inflammatory markers. Prog Neuropsychopharmacol Biol Psychiatry2025; 138: 111298.
54.
HeppnerPSCrawfordEFHajiUA, et al.The association of posttraumatic stress disorder and metabolic syndrome: a study of increased health risk in veterans. BMC Med2009; 7: 1.
55.
MohlenhoffBSO'DonovanAWeinerMW, et al.Dementia risk in posttraumatic stress disorder: the relevance of sleep-related abnormalities in brain structure, amyloid, and inflammation. Curr Psychiatry Rep2017; 19: 89.
56.
DelicVRatliffWACitronBA. Sleep deprivation, a link between post-traumatic stress disorder and Alzheimer's disease. J Alzheimers Dis2021; 79: 1443–1449.
57.
Duarte-ZambranoFBarreroJAMockusI. Cerebrospinal fluid levels of hypothalamic-pituitary-adrenal axis hormones in MCI and dementia due to Alzheimer's disease: a systematic review. Dement Neuropsychol2023; 17: e20230031.
58.
DunlopBWWongA. The hypothalamic-pituitary-adrenal axis in PTSD: pathophysiology and treatment interventions. Prog Neuropsychopharmacol Biol Psychiatry2019; 89: 361–379.
59.
ZhuYGaoHTongL, et al.Emotion regulation of hippocampus using real-time fMRI neurofeedback in healthy human. Front Hum Neurosci2019; 13: 242.
60.
BarkusCMcHughSBSprengelR, et al.Hippocampal NMDA receptors and anxiety: at the interface between cognition and emotion. Eur J Pharmacol2010; 626: 49–56.
61.
SweattJD. Hippocampal function in cognition. Psychopharmacology (Berl)2004; 174: 99–110.
62.
HuntMCAlexsonSE. The role Acyl-CoA thioesterases play in mediating intracellular lipid metabolism. Prog Lipid Res2002; 41: 99–130.
63.
BrockerCCarpenterCNebertDW, et al.Evolutionary divergence and functions of the human acyl-CoA thioesterase gene (ACOT) family. Hum Genomics2010; 4: 411–420.
64.
ZengQGongYZhuN, et al.Lipids and lipid metabolism in cellular senescence: emerging targets for age-related diseases. Ageing Res Rev2024; 97: 102294.
65.
MutluASDuffyJWangMC. Lipid metabolism and lipid signals in aging and longevity. Dev Cell2021; 56: 1394–1407.
66.
YoonHShawJLHaigisMC, et al.Lipid metabolism in sickness and in health: emerging regulators of lipotoxicity. Mol Cell2021; 81: 3708–3730.
67.
EbertDHallerRGWaltonME. Energy contribution of octanoate to intact rat brain metabolism measured by 13C nuclear magnetic resonance spectroscopy. J Neurosci2003; 23: 5928–5935.
68.
KreftMBakLKWaagepetersenHS, et al.Aspects of astrocyte energy metabolism, amino acid neurotransmitter homoeostasis and metabolic compartmentation. ASN Neuro2012; 4: e00086.
69.
Di PaoloGKimTW. Linking lipids to Alzheimer's disease: cholesterol and beyond. Nat Rev Neurosci2011; 12: 284–296.
70.
FlowersABell-TeminHJallohA, et al.Proteomic anaysis of aged microglia: shifts in transcription, bioenergetics, and nutrient response. J Neuroinflammation2017; 14: 96.
71.
MontaniL. Lipids in regulating oligodendrocyte structure and function. Semin Cell Dev Biol2021; 112: 114–122.
72.
NasrabadySERizviBGoldmanJE, et al.White matter changes in Alzheimer's disease: a focus on myelin and oligodendrocytes. Acta Neuropathol Commun2018; 6: 22.
73.
LiLLeiDLiL, et al.White matter abnormalities in post-traumatic stress disorder following a specific traumatic event. EBioMedicine2016; 4: 176–183.
74.
QinQYinYXingY, et al.Lipid metabolism in the development and progression of vascular cognitive impairment: a systematic review. Front Neurol2021; 12: 709134.
75.
PifferiFLaurentBPlourdeM. Lipid transport and metabolism at the blood-brain interface: implications in health and disease. Front Physiol2021; 12: 645646.
76.
ClelandNRWBruceKD. Fatty acid sensing in the brain: the role of glial-neuronal metabolic crosstalk and horizontal lipid flux. Biochimie2024; 223: 166–178.
77.
XieZJonesADeeneyJT, et al.Inborn errors of long-chain fatty acid beta-oxidation link neural stem cell self-renewal to autism. Cell Rep2016; 14: 991–999.
78.
KouJKovacsGGHoftbergerR, et al.Peroxisomal alterations in Alzheimer's disease. Acta Neuropathol2011; 122: 271–283.
79.
YinF. Lipid metabolism and Alzheimer's disease: clinical evidence, mechanistic link and therapeutic promise. FEBS J2023; 290: 1420–1453.
80.
XuJSiHZengY, et al.Transcriptome-wide association study identifies new susceptibility genes for degenerative cervical spondylosis. Bone Joint Res2023; 12: 80–90.
81.
MancusoNGaytherSGusevA, et al.Large-scale transcriptome-wide association study identifies new prostate cancer risk regions. Nat Commun2018; 9: 4079.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
